PENGUIN BIO
Live / Applied — Second extension granted (statement of use) (as of 12 Nov 2025)
What this means for you
Not registered yet, but its 23 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98514367
- Mark type
- Stylized text
- Filed
- 23 Apr 2024
- Published for opposition
- 03 Dec 2024
- Attorney of record
- Aaron Y. Silverstein
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of metabolic diseases; Pharmaceutical preparations for the treatment of metabolic diseases
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields
Owner
- PENGUIN BIO CORP., NEW YORK, NY, US
- Ghrelco, Inc., New York, NY, US
- Ghrelco, Inc., New York, NY, US
Prosecution history
- 13 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Nov 2025 — SOU EXTENSION 2 GRANTED
- 12 Nov 2025 — SOU EXTENSION 2 FILED
- 12 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 08 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2025 — SOU EXTENSION 1 GRANTED
- 07 May 2025 — SOU EXTENSION 1 FILED
- 07 May 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Apr 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2024 — PUBLISHED FOR OPPOSITION
- 27 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Nov 2024 — ASSIGNED TO EXAMINER